Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Gene Therapy Expressing Platelet-Derived Factor VIII for Correction of Hemophilia Α with a History of Inhibitors

David A. Wilcox, Myriam Armant, Lynn Malec, Qizhen Shi, Bryon D. Johnson, Huiqing Xu, Lily M. Du, Lisa J. Duffy, Frederic D. Bushman, James H. Jerkins, Peiman Hematti, Ruta Brazauskas, Shawn M. Jobe, Parameswaran N. Hari, Mary Eapen

Blood (2023) 142 (Supplement 1): 2249.

https://doi.org/10.1182/blood-2023-172845

Published: 2023

Journal Articles

Adaptive Manufacturing of LV20.19 CAR T-Cells for Relapsed, Refractory Mantle Cell Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Tyce Kearl, Anthony Zamora, Jessica Neumann, Parameswaran N. Hari, Dina Schneider, Walter Longo, Peiman Hematti, Bryon D. Johnson, Mehdi Hamadani, Timothy S. Fenske

Blood (2023) 142 (Supplement 1): 1024.

https://doi.org/10.1182/blood-2023-173954

Published: 2023

Journal Articles

Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)

Blood (2022) 140 (Supplement 1): 4636–4638.

https://doi.org/10.1182/blood-2022-169452

Published: 2022

Journal Articles

Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR)

Abu-Sayeef Mirza, Chitra Hosing, Francine M. Foss, Soyoung Kim, Amy Moskop, Temitope Oloyede, Sairah Ahmed, Peiman Hematti, Cameron J. Turtle, Marcelo C. Pasquini, Lohith Gowda

Blood (2022) 140 (Supplement 1): 4633–4635.

https://doi.org/10.1182/blood-2022-163750

Published: 2022

Journal Articles

Regional Differences in Salaries of First Year Fellows in Hematology-Oncology Fellowship Programs in the United States

Moazzam Shahzad, Ali Hussain, Muhammad Fareed Khalid, Farrukh Munir, Huda Fatima, Qamar Iqbal, Murali Krishna Gurram, Iqra Anwar, Sibgha Gull Chaudhary, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2022) 140 (Supplement 1): 13068–13069.

https://doi.org/10.1182/blood-2022-157474

Published: 2022

Journal Articles

Outcomes with Viral Specific T-Cells in Cytomegalovirus, Adenovirus, and BK Virus Infections after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Maheen Zaidi, Qamar Iqbal, Ezza Tariq, Reem Sulaiman, Fizza Mohsin, Munawwar Hussain, Ali Hussain, Iqra Anwar, Sibgha Gull Chaudhary, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2022) 140 (Supplement 1): 12844–12845.

https://doi.org/10.1182/blood-2022-155801

Published: 2022

Journal Articles

Outcomes with Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Qamar Iqbal, Sara J Zaidi, Amna Y Shah, Reem Sulaiman, Mamoon Ahmed, Ammad Naeem, Sorosh Daud, Iqra Anwar, Sibgha Gull Chaudhary, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2022) 140 (Supplement 1): 12884–12885.

https://doi.org/10.1182/blood-2022-155832

Published: 2022

Journal Articles

Outcomes with Eltrombopag for Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Qamar Iqbal, Farrukh Munir, Sakina Abbas, Maheen Zaidi, Nimra Shafi, Muhammad Sohaib, Waleed Ahmed Mir, Iqra Anwar, Sibgha Gull Chaudhary, Maggie Nelson, Philip Lubanski, Zahra Mahmoudjafari, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2022) 140 (Supplement 1): 12846–12847.

https://doi.org/10.1182/blood-2022-155813

Published: 2022

Journal Articles

Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in NPM1-Mutated Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Ali Hussain, Moazzam Shahzad, Sakina Abbas, Junaid Khan, Ali Hassan Mushtaq, Muhammad Fareed Khalid, Murali Krishna Gurram, Iqra Anwar, Sibgha Gull Chaudhary, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2022) 140 (Supplement 1): 12967–12968.

https://doi.org/10.1182/blood-2022-157094

Published: 2022

Journal Articles

Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission

Blood (2022) 139 (9): 1330–1339.

https://doi.org/10.1182/blood.2021013289

Published: 2022

Includes: Supplemental data

Journal Articles

Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Sibgha Gull Chaudhary, Ali Hussain, Fatima Ali, Ayesha Khalid, Ezza Tariq, Muhammad Usman Zafar, Muhammad Arslan, Iqra Anwar, Rajat Bansal, Peiman Hematti, Tara L. Lin, Sunil Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 4825.

https://doi.org/10.1182/blood-2021-145666

Published: 2021

Journal Articles

Use of Endpoints in Phase III Randomized Controlled Trials for Acute Myeloid Leukemia over the Last 15 Years: A Systematic Review

Moazzam Shahzad, Muhammad Arslan, Sibgha Gull Chaudhary, Raheel S Siddiqui, Ezza Tariq, Faryal Murtaza, Sara Shahid, Raza Ur Rahman, Iqra Anwar, Ali Hussain, Abdulraheem Yacoub, Peiman Hematti, Tara L. Lin, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 4389.

https://doi.org/10.1182/blood-2021-145545

Published: 2021

Journal Articles

Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation over the Last 15 Years: A Systematic Review

Muhammad Umair Mushtaq, Moazzam Shahzad, Ezza Tariq, Muhammad Arslan, Sara Shahid, Raza Ur Rahman, Faryal Murtaza, Iqra Anwar, Qamar Iqbal, Sibgha Gull Chaudhary, Ramesh Balusu, Nausheen Ahmed, Peiman Hematti, Sunil Abhyankar, Joseph P. McGuirk, Leyla Shune

Blood (2021) 138 (Supplement 1): 4910.

https://doi.org/10.1182/blood-2021-146218

Published: 2021

Journal Articles

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

Blood (2021) 138 (Supplement 1): 899.

https://doi.org/10.1182/blood-2021-149659

Published: 2021

Journal Articles

Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Muhammad Salman Faisal, Ezza Tariq, Ali Hussain, Muhammad Arslan, Venkata Thammineni, Leena Syed, Alvina Karam, Iqra Anwar, Sibgha Gull Chaudhary, Nausheen Ahmed, Tara L. Lin, Sunil Abhyankar, Peiman Hematti, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 3961.

https://doi.org/10.1182/blood-2021-152122

Published: 2021

Journal Articles

Outcomes with Hematopoietic Stem Cell Transplantation in Secondary Hemophagocytic Lymphohistiocytosis: A Systematic Review and Meta-Analysis

Qamar Iqbal, Moazzam Shahzad, Ezza Tariq, Laila Hashim, Abdul Basit, Kashf Zaidi, Muhammad Salman Faisal, Iqra Anwar, Sibgha Gull Chaudhary, Ramesh Balusu, Nausheen Ahmed, Leyla Shune, Peiman Hematti, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 3963.

https://doi.org/10.1182/blood-2021-149722

Published: 2021

Journal Articles

Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Following Reduced Intensity Conditioning: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, Naira Fatima, Muhammad Arslan, Muhammad Usman Zafar, Amna Y Shah, Mamoon Ahmed, Iqra Anwar, Nausheen Ahmed, Leyla Shune, Ramesh Balusu, Peiman Hematti, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 2863.

https://doi.org/10.1182/blood-2021-146051

Published: 2021

Journal Articles

Differentiation of a CD4/CD8αβ Double Positive T Cell Population from the CD8 Pool Is Both Predictive and Sufficient to Mediate Graft-Vs-Host Disease

Nicholas J. Hess, David Turicek, Amy Hudson, Peiman Hematti, Jenny Gumperz, Christian M. Capitini

Blood (2021) 138 (Supplement 1): 2761.

https://doi.org/10.1182/blood-2021-147304

Published: 2021

Journal Articles

Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Muhammad Umair Mushtaq, Moazzam Shahzad, Muhammad Usman Zafar, Muhammad Arslan, Ezza Tariq, Naira Fatima, Syeda Sadia Bokhari, Javeria Shahani, Iqra Anwar, Sibgha Gull Chaudhary, Anurag K. Singh, Sunil Abhyankar, Natalie S. Callander, Peiman Hematti, Joseph P. McGuirk

Blood (2021) 138 (Supplement 1): 1848.

https://doi.org/10.1182/blood-2021-145632

Published: 2021

NARROW

Gene Therapy Expressing Platelet-Derived Factor VIII for Correction of Hemophilia Α with a History of Inhibitors

Adaptive Manufacturing of LV20.19 CAR T-Cells for Relapsed, Refractory Mantle Cell Lymphoma

Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)

Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR)

Regional Differences in Salaries of First Year Fellows in Hematology-Oncology Fellowship Programs in the United States

Outcomes with Viral Specific T-Cells in Cytomegalovirus, Adenovirus, and BK Virus Infections after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Outcomes with Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Outcomes with Eltrombopag for Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in NPM1-Mutated Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission

Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Use of Endpoints in Phase III Randomized Controlled Trials for Acute Myeloid Leukemia over the Last 15 Years: A Systematic Review

Top 100 Cited Articles on Hematopoietic Stem Cell Transplantation: A Bibliometric Analysis

Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation over the Last 15 Years: A Systematic Review

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis

Outcomes with Hematopoietic Stem Cell Transplantation in Secondary Hemophagocytic Lymphohistiocytosis: A Systematic Review and Meta-Analysis

Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Following Reduced Intensity Conditioning: A Systematic Review and Meta-Analysis

Differentiation of a CD4/CD8αβ Double Positive T Cell Population from the CD8 Pool Is Both Predictive and Sufficient to Mediate Graft-Vs-Host Disease

Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only